Marcis Bajars

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

Fabrice Barlési, Johan Vansteenkiste, David R. Spigel et al. · The Lancet Oncology · 2018 · 397 citations

Medicine, Oncology, Pharmacology +11

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma

Sandra P. D’Angelo, Jeffery S. Russell, Célèste Lebbé et al. · JAMA Oncology · 2018 · 368 citations · Full text

Medicine, Oncology, Pharmacology +17

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

Sandra P. D’Angelo, Shailender Bhatia, Andrew S. Brohl et al. · Journal for ImmunoTherapy of Cancer · 2020 · 197 citations · Full text

Medicine, Oncology, Pharmacology +17

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Andrew D.J. Pearson, Claudia Rössig, Giovanni Lesa et al. · European Journal of Cancer · 2020 · 68 citations · Full text

Medicine, Oncology, Pediatrics +17

Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial

Ulka N. Vaishampayan, Patrick Schöffski, Alain Ravaud et al. · Journal for ImmunoTherapy of Cancer · 2019 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17